Suffering from Bipolar Disorder or Depression?
Therapy not enough?
Treatment Available, Most Insurance Accepted.
Call Today 877-331-2545

October 2, 2004

Abilify approved for Bipolar Disorder Mania

Bristol-Myers Squibb (bmy) and partner Otsuka Pharmaceutical received approval of Abilify, a drug for the treatment of acute bipolar mania, from the Food and Drug Administration. Abilify was previously approved in 2002 by the FDA to treat schizophrenia.


Post a comment

Type the characters you see in the picture above.

Remember Me?